Volume 26, Number 10—October 2020
Research Letter
Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan
Table
Characteristic | No. assessed | Value* |
---|---|---|
Age, y |
54 |
45.5 (20–81) |
Sex | ||
M | 39 | 39 (72.2) |
F |
15 |
15 (27.8) |
Body mass index, kg/m2 | 54 | 23.7 (15.9–51.1) |
Current smoker | 48 | 16 (33.3) |
Days from symptom onset to admission |
54 |
9 (2–25) |
Vital signs at admission | ||
Body temperature, °C | 54 | 37.2 (36.1–39.2) |
Pulse rate, beats/min | 54 | 84 (62–134) |
Systolic blood pressure, mm Hg | 54 | 116 (80–170) |
Diastolic blood pressure, mm Hg | 54 | 70.5 (51–124) |
Respiratory rate, breaths/min | 53 | 18 (16–26) |
Percutaneous oxygen saturation, %† |
54 |
97 (92–100) |
Highest temperature during admission,°C | 54 | |
<37.5 | 54 | 27 (50.0) |
37.5–38.9 | 54 | 20 (37.0) |
>38.9°C |
54 |
7 (13.0) |
Laboratory findings at admission | ||
Leukocyte count, cells/mm3 | 54 | 5,530 (2,690–16,700) |
Lymphocyte count, cells/mm3 | 54 | 1,251 (381–2,852) |
Hemoglobin, g/dL | 54 | 14.7 (11.1–17.3) |
Platelet count, × 1,000/mm3 | 54 | 231 (106–444) |
Blood urea nitrogen, mmol/L | 54 | 4.3 (2.1–7.9) |
Creatinine, μmol/L | 54 | 69.0 (34.5–120.2) |
Sodium, mmol/L | 53 | 139 (132–148) |
Potassium, mmol/L | 53 | 4.0 (3.1–4.8) |
Creatine kinase, U/L | 52 | 74 (22–674) |
C-reactive protein, mg/L | 54 | 17.9 (0.1–215.6) |
Brain natriuretic peptide, pg/mL | 52 | 5.8 (5.8–43.2) |
D-dimer, mg/L |
50 |
0.5 (0.5–6.5) |
Concurrent conditions | ||
Hypertension | 54 | 8 (14.8) |
Diabetes | 54 | 5 (9.3) |
Chronic obstructive pulmonary disease | 54 | 1 (1.9) |
Coronary heart disease | 54 | 0 (0) |
HIV Infection | 54 | 4 (7.4) |
*Values are median (range) or no. (%).
†Nine patients required oxygen therapy at admission.
Page created: June 29, 2020
Page updated: September 17, 2020
Page reviewed: September 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.